BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Pathology News - ECPv6.16.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Pathology News
X-ORIGINAL-URL:https://www.pathologynews.com
X-WR-CALDESC:Events for Pathology News
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:Europe/London
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20240331T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20241027T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0000
TZOFFSETTO:+0100
TZNAME:BST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0100
TZOFFSETTO:+0000
TZNAME:GMT
DTSTART:20261025T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:UTC
BEGIN:STANDARD
TZOFFSETFROM:+0000
TZOFFSETTO:+0000
TZNAME:UTC
DTSTART:20240101T000000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20250909T160000
DTEND;TZID=Europe/London:20250909T170000
DTSTAMP:20260828T064319
CREATED:20250822T135627Z
LAST-MODIFIED:20250919T113511Z
UID:100115229-1757433600-1757437200@www.pathologynews.com
SUMMARY:Mastering Image Quality Control with AIRA Matrix
DESCRIPTION:Artificial intelligence is transforming how laboratories and life science organizations approach quality control. This webinar will answer the key question: Why address quality control issues with AI? We’ll explore the benefits of AI-driven solutions\, highlight differentiating features\, and provide a live product demonstration to show how Aira Matrix can improve efficiency and consistency in lab workflows. Attendees will gain practical insights into how AI can help reduce errors\, streamline processes\, and support more reliable outcomes. \nThe session will be led by Marco Comianos\, who heads Aira Matrix’s commercial organization in the United States and Canada. With over 25 years of experience in sales\, marketing\, and commercial leadership across healthcare and life sciences\, including roles in medical imaging\, EMR\, and healthcare AI. Marco brings deep expertise in aligning innovative technologies with real-world clinical and research needs. \nLearning Objectives\n\nWhy addressing quality control with AI matters\nHow Aira Matrix differentiates itself in the market\nKey product features and their impact on efficiency\nA live demo of the platform in action\n\nRegister Now
URL:https://www.pathologynews.com/event/mastering-image-quality-control-with-aira-matrix/
LOCATION:Online
CATEGORIES:PN Webinar
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/08/AIM-WEB0-Featured-Image.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=UTC:20250917T150000
DTEND;TZID=UTC:20250917T160000
DTSTAMP:20260828T064319
CREATED:20250818T110738Z
LAST-MODIFIED:20250919T113433Z
UID:100115115-1758121200-1758124800@www.pathologynews.com
SUMMARY:Future-ready Pathology: Embracing digital transformation for improved patient care
DESCRIPTION:0000Days00Hrs00Min00SecRegister using the link\, available below! \nTwo leading European hospital networks—Hospital Universitario Quirónsalud Madrid and Groupe Hospitalier Paris Saint-Joseph/Hôpital Marie-Lannelongue—shared how they transformed pathology services through digital innovation in collaboration with Philips. The webinar highlights how cloud infrastructure enables scalable\, compliant storage; AI enhances diagnostic speed and quality; and integrated diagnostics are bringing pathology and radiology together for more connected\, patient-centered care. \nLearning Objectives:\n\nUnderstand how digital pathology enables subspecialty-based collaboration across hospitals\, enhancing diagnostic quality and operational flexibility.\nExplore how AI tools support lesion detection and quantification to improve diagnostic efficiency and accuracy.\nLearn how end-to-end support from Philips—including infrastructure planning and cloud integration—facilitates scalable digital transformation.\nRecognize the role of cloud-based storage and intelligent retention policies in streamlining data management and enabling integrated diagnostics.\n\nREGISTER HERE
URL:https://www.pathologynews.com/event/future-ready-pathology-embracing-digital-transformation-for-improved-patient-care/
CATEGORIES:PN Webinar
ATTACH;FMTTYPE=image/jpeg:https://www.pathologynews.com/wp-content/uploads/2025/08/PHI-WEB0-Featured-Image.jpg
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/London:20250925T170000
DTEND;TZID=Europe/London:20250925T180000
DTSTAMP:20260828T064319
CREATED:20250520T203901Z
LAST-MODIFIED:20250919T113423Z
UID:100112612-1758819600-1758823200@www.pathologynews.com
SUMMARY:Prognostic Risk Profiling from Digitized H&E: a look at new international performances of an AI model for breast cancer
DESCRIPTION:0000Days00Hrs00Min00SecRegister using the link\, available below! \nJoin expert pathologist\, Magali Lacroix-Triki\, and Owkin senior data scientist\, Valentin Guary\, as they present new findings on RlapsRisk® BC\, an innovative AI-driven solution for breast cancer recurrence risk assessment from digital pathology slides. This webinar will showcase comprehensive data comparing RlapsRisk® BC’s performance against traditional clinical scores and established molecular tests. Our panel will discuss how this revolutionary tool helps to enhance prognostic accuracy and has the potential to transform treatment decision-making in breast cancer care. \nAttendees will gain valuable insights into:\n▪ The impact of AI-powered digital pathology solutions for outcome and prognostic prediction\n▪ Latest performance results from ongoing studies\n▪ First comparisons with current testing approaches\n▪ Real-world implementation experiences\n▪ Potential impact on treatment planning and patient care \nRlapsRisk® BC is under development and not for clinical use. It is not FDA cleared or approved in the USA. RlapsRisk® BC is developed within the PortrAIt consortium\, a french consortium financed by the government within the framework of France 2030 and by the European Union – Next Generation EU within the framework of the France Relance Plan. \nRegister Here
URL:https://www.pathologynews.com/event/prognostic-risk-profiling-from-digitized-he-a-look-at-new-international-performances-of-an-ai-model-for-breast-cancer/
LOCATION:Online
CATEGORIES:PN Webinar
ATTACH;FMTTYPE=image/gif:https://www.pathologynews.com/wp-content/uploads/2025/05/Featured-Image-Breast-Cancer-Recurrence-Risk-Assessment-from-Digitized-HE-with-RlapsRisk-BC-a-Clinically-Validated-AI-Prognostic-Solution.gif
END:VEVENT
END:VCALENDAR